Semaglutide or Tirzepatide: GLP-1 receptor agonists work through entirely different mechanisms (appetite suppression, glucose regulation, delayed gastric emptying) compared to AOD-9604s direct lipolytic effects
Quality and Handling Reliable outcomes start with clean synthesis and transparent testing
Slowly draw your bacteriostatic water into a sterile insulin syringe, then inject it gently down the inner glass wall of the peptide vial, never directly onto the lyophilised powder
That is what turns BPC-157 from an online gamble into a clinical tool
Unlike many weight loss compounds that work through appetite suppression or metabolic stimulation, AOD-9604 directly targets fat tissue at the receptor level, making it one of the most precise fat reduction tools available in peptide therapy
These medical-grade patches follow a 12-hour wear cycle during an initial 3-day loading phase, transitioning to a once-daily maintenance schedule (12 hours on, 12 hours off) to sustain benefits